News & Updates

Diabetes mellitus (DM) and obesity are two of the most prevalent chronic health conditions worldwide, affecting millions of individuals globally.1,2 As the landscape of diabetes therapy continues to evolve, it is becoming increasingly clear that a one-size-fits-all approach is no longer sufficient. By considering a range of factors beyond just glucose control, healthcare providers can provide more effective, personalized care that results in better outcomes for patients with diabetes. 

Adding glucagon-like peptide-1 receptor agonists (GLP1RA) onto metformin, sulfonylurea, or insulin treatment alone or in combination appears to reduce the incidence of major adverse cardiac events (MACE) and heart failure (HF) hospitalization relative to treatment with dipeptidyl peptidase-4 inhibitors (DPP4i), suggests a study.

Artificial intelligence (AI) can help diagnose thyroid eye disease (TED) and assess for severity by analysing CT scans, reports an expert at ARVO 2023.

An association is seen between higher energy expenditure (EE) and higher all-cause mortality among younger postmenopausal women, according to a US study. This link is partially explained by weight and weight change.

For individuals with overweight or obesity, eating mixed nuts appears to help lower body fat without significant changes in body weight or body mass index (BMI), as reported in a study. Furthermore, there is no significant effect on low-density lipoprotein cholesterol (LDL-C) or lipoprotein(a) (Lp[a]).